All News

In response to a number of deaths and serious adverse events reported by patients taking Fentora, warning letters were sent to health care professionals. According to Cephalon, Inc., the deaths primarily occurred as a result of improper patient selection, improper dosing, and/or improper product substitution.

The new dynamic duo

Is a new effort to codevelop drugs and diagnostics just an interesting concept or the future of drug development?